Oxycontin Patents Not Infringed, Drug Cos. Say At Trial
Impax Laboratories Inc. and other drug makers said Monday that generic versions of Purdue Pharma LP's OxyContin do not infringe Purdue-held patents, opening a patent trial that could help end Purdue's...To view the full article, register now.
Already a subscriber? Click here to view full article